Drug Approvals | eHealth News | Page 35

The U.S. Food and Drug Administration on Monday expanded its approval for the Optune device to include newly diagnosed glioblastoma multiforme.

FDA Approves Optune Device for Newly Diagnosed Glioblastoma

HealthDay.com - Oct 7, 2015 0

Newly sanctioned to treat just-diagnosed patients, in combination with temozolomide

Aristada (aripiprazole lauroxil) extended-release injection has been approved by the U.S. Food and Drug Administration to treat schizophrenia

FDA OKs Long-Acting Atypical Antipsychotic for Schizophrenia

HealthDay.com - Oct 6, 2015 0

Aristada (aripiprazole lauroxil) is injected every four-to-six weeks

Keytruda (pembrolizumab) has been approved by the U.S. Food and Drug Administration to treat advanced cases of non-small-cell lung cancer with tumors that express the PD-L1 protein. Keytruda is approved for use with the PD-L1 IHC 22C3 pharmDx test

FDA Approves Keytruda for Advanced NSCLC

HealthDay.com - Oct 2, 2015 0

Approved for use with PD-L1 IHC 22C3 pharmDx test

The combination pill Lonsurf (trifluridine and tipiracil) has been approved by the U.S. Food and Drug Administration to treat metastatic colorectal cancer in patients who aren't responding to other treatments

FDA Approves Lonsurf for Metastatic Colorectal Cancer

HealthDay.com - Sep 23, 2015 0

For patients with metastatic CRC previously treated with chemotherapy, biological therapy

A new antipsychotic drug to treat schizophrenia and bipolar disorder in adults has been approved by the U.S. Food and Drug Administration. The drug

FDA Approves New Drug for Schizophrenia, Bipolar Disorder

HealthDay.com - Sep 18, 2015 0

Vraylar is an atypical antipsychotic taken once a day

Varubi (rolapitant) has been approved by the U.S. Food and Drug Administration to prevent delayed phase chemotherapy-induced nausea and vomiting.

FDA Approves Varubi for Chemo-Induced Nausea, Vomiting

HealthDay.com - Sep 2, 2015 0

For prevention of the delayed phase of nausea, vomiting caused by chemotherapy

Repatha (evolocumab) has been approved by the U.S. Food and Drug Administration

FDA Approves Repatha for Certain Patients With High Cholesterol

HealthDay.com - Aug 28, 2015 0

Approved for patients unable to get LDL cholesterol under control with current treatment options

U.S. Food and Drug Administration approval of the drug Promacta (eltrombopag) has been expanded to include children 1 year and older with chronic immune thrombocytopenic purpura.

Promacta Approval Expanded for Children With Chronic ITP

HealthDay.com - Aug 24, 2015 0

Builds on recent approval for ages 6 years and up for chronic immune thrombocytopenic purpura

Addyi (flibanserin) has been approved by the U.S. Food and Drug Administration as the first drug to treat generalized hypoactive sexual desire disorder among premenopausal women. The drug is for women who do not have an underlying physical or psychological cause for the disorder

FDA Approves Libido Pill for Women

HealthDay.com - Aug 19, 2015 0

Addyi to treat generalized hypoactive sexual desire disorder among premenopausal women

The ReShape Integrated Dual Balloon System has been approved by the U.S. Food and Drug Administration to combat adult obesity. Inflated inside the stomach

FDA Approves Balloon Device to Treat Obesity

HealthDay.com - Jul 29, 2015 0

Inflated in stomach, it may create sense of fullness

1...343536...40 Page 35 of 40

Archives